TG Therapeutics | TGTX - Ebit


TG Therapeutics reported $29.36M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
AbbVie USD 1.45B 4.26B Sep/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Amgen USD 3.96B 464M Dec/2025
Ardelyx USD 7.12M 19.62M Sep/2025
Arrowhead Research USD 57.82M 223.36M Sep/2025
Bayer EUR -399M 363M Sep/2025
Biogen USD 659.6M 157M Sep/2025
Corcept Therapeutics USD 10.22M 16.46M Sep/2025
Dynavax Technologies USD 21.27M 10.41M Sep/2025
Gilead Sciences USD 3.51B 810M Sep/2025
J&J USD 5.11B 2.3B Dec/2025
Novartis USD -9.19B 13.87B Jun/2025
PTC Therapeutics USD 3.49M 38.35M Sep/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
TG Therapeutics USD 29.36M 5.48M Sep/2025
Vertex Pharmaceuticals USD 1.24B 84.6M Sep/2025